Grifols Faces Scrutiny After Two Deaths at Plasma Harvesting Sites
Event summary
- Two deaths reported at Grifols-owned plasma collection facilities, prompting a press conference by health coalitions.
- Manitoba and Ontario Health Coalitions to address safety concerns and ownership of the blood system.
- Press conference scheduled for March 13, 2026, featuring key health coalition representatives.
- Coalitions have previously raised warnings about safety and control of the blood system.
The big picture
The tragic deaths at Grifols' plasma harvesting sites highlight ongoing concerns about safety and the privatization of the blood system. This incident could accelerate regulatory changes and public pressure for stricter oversight in the biopharmaceutical industry. The scale of Grifols' operations makes this a critical issue for investors and operators in the healthcare sector.
What we're watching
- Regulatory Scrutiny
- How increased regulatory scrutiny will impact Grifols' operations and reputation.
- Public Trust
- Whether Grifols can restore public trust following the tragic incidents.
- Industry Standards
- The pace at which industry standards for plasma harvesting will be revised.
Related topics